Home

erózió kráter Téglalap bcr abl kinase El csapás Eltéríteni

STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia - The Lancet Oncology
STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia - The Lancet Oncology

IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells
IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells

Flying under the radar: the new wave of BCR–ABL inhibitors | Nature Reviews Drug Discovery
Flying under the radar: the new wave of BCR–ABL inhibitors | Nature Reviews Drug Discovery

Regulation of the c-Abl and Bcr–Abl tyrosine kinases | Nature Reviews Molecular Cell Biology
Regulation of the c-Abl and Bcr–Abl tyrosine kinases | Nature Reviews Molecular Cell Biology

Hematology Reports | Free Full-Text | Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review
Hematology Reports | Free Full-Text | Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review

JCI - Applying the discovery of the Philadelphia chromosome
JCI - Applying the discovery of the Philadelphia chromosome

shRNA Loss-of-Function Screen Identifies Alternate Pathway for BCR-ABL - Cellecta
shRNA Loss-of-Function Screen Identifies Alternate Pathway for BCR-ABL - Cellecta

Bcr-Abl tyrosine-kinase inhibitor - Wikipedia
Bcr-Abl tyrosine-kinase inhibitor - Wikipedia

PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar
PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar

BCR-ABL activates multiple downstream signaling pathways that... | Download Scientific Diagram
BCR-ABL activates multiple downstream signaling pathways that... | Download Scientific Diagram

Frontiers | The Discovery of Novel BCR-ABL Tyrosine Kinase Inhibitors Using a Pharmacophore Modeling and Virtual Screening Approach
Frontiers | The Discovery of Novel BCR-ABL Tyrosine Kinase Inhibitors Using a Pharmacophore Modeling and Virtual Screening Approach

Disabling Abl—Perspectives on Abl kinase regulation and cancer therapeutics: Cancer Cell
Disabling Abl—Perspectives on Abl kinase regulation and cancer therapeutics: Cancer Cell

Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia

Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance | Haematologica
Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance | Haematologica

Dasatinib is an Orally Active Dual Bcr-Abl and Src Family Tyrosine Kinase Inhibitor | MedChemExpress
Dasatinib is an Orally Active Dual Bcr-Abl and Src Family Tyrosine Kinase Inhibitor | MedChemExpress

IJMS | Free Full-Text | The Role of Mitochondrial DNA Damage and Repair in the Resistance of BCR/ABL-Expressing Cells to Tyrosine Kinase Inhibitors
IJMS | Free Full-Text | The Role of Mitochondrial DNA Damage and Repair in the Resistance of BCR/ABL-Expressing Cells to Tyrosine Kinase Inhibitors

Figure 1 from STI571: targeting BCR-ABL as therapy for CML. | Semantic Scholar
Figure 1 from STI571: targeting BCR-ABL as therapy for CML. | Semantic Scholar

Regulatory Molecules and Corresponding Processes of BCR-ABL Protein Degradation
Regulatory Molecules and Corresponding Processes of BCR-ABL Protein Degradation

Mechanism of action of BCR (breakpoint cluster region)-ABL (Abelson 1... | Download Scientific Diagram
Mechanism of action of BCR (breakpoint cluster region)-ABL (Abelson 1... | Download Scientific Diagram

Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia | Nature Reviews Cancer
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia | Nature Reviews Cancer

Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet
Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet

Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia | NEJM
Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia | NEJM

Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect
Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect

Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface* - Journal of Biological Chemistry
Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface* - Journal of Biological Chemistry

Mechanism of Action of BCR-ABL and of Its Inhibition by Imatinib. Panel... | Download Scientific Diagram
Mechanism of Action of BCR-ABL and of Its Inhibition by Imatinib. Panel... | Download Scientific Diagram

The Paradigm of Targeting an Oncogenic Tyrosine Kinase: Lesson from BCR-ABL | IntechOpen
The Paradigm of Targeting an Oncogenic Tyrosine Kinase: Lesson from BCR-ABL | IntechOpen